Structure of covid19

Aus coViki
(Unterschied zwischen Versionen)
Wechseln zu: Navigation, Suche
(genome)
K (Uptake: cathepsin L)
 
(25 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt)
Zeile 1: Zeile 1:
 
{{pnc}}
 
{{pnc}}
 
__NOTOC__
 
__NOTOC__
 +
{{ft|I}}
 +
----
 +
major items will be recollected into the pharmacophore section {{qt|PHA pharmacophore by screened target}}
 +
----
 
===integrative papers===
 
===integrative papers===
{{tp|p=32507543|t=2020. Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2.|pdf=|usr=007}}
+
{{ttp|p=32507543|t=2020. Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2.|pdf=|usr=007}}
 
{{tp|p=32181901|t=ä. A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019?nCoV) |pdf=|usr=}}
 
{{tp|p=32181901|t=ä. A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019?nCoV) |pdf=|usr=}}
 
{{tp|p=32296735|t=2020. Prudently conduct the engineering and synthesis of the SARS-CoV-2 virus |pdf=|usr=}}
 
{{tp|p=32296735|t=2020. Prudently conduct the engineering and synthesis of the SARS-CoV-2 virus |pdf=|usr=}}
 
{{tp|p=C7085496|t=ä. Structural, glycosylation and antigenic variation between 2019 novel coronavirus  (2019-nCoV) and SARS coronavirus (SARS-CoV) |pdf=|usr=}}
 
{{tp|p=C7085496|t=ä. Structural, glycosylation and antigenic variation between 2019 novel coronavirus  (2019-nCoV) and SARS coronavirus (SARS-CoV) |pdf=|usr=}}
 
{{tp|p=32254054|t=2020. Visualizing an unseen enemy; mobilizing structural biology to counter COVID-191 |pdf=|usr=}}
 
{{tp|p=32254054|t=2020. Visualizing an unseen enemy; mobilizing structural biology to counter COVID-191 |pdf=|usr=}}
{{tp|p=32254048|t=2020. Visualizing an unseen enemy; mobilizing structural biology to counter COVID-191 |pdf=|usr=}}
 
 
{{tp|p=32311462|t=2020. On the molecular determinants of the SARS-CoV-2 attack |pdf=|usr=}}
 
{{tp|p=32311462|t=2020. On the molecular determinants of the SARS-CoV-2 attack |pdf=|usr=}}
 
{{tp|p=32229288|t=ä. Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy |pdf=|usr=}}
 
{{tp|p=32229288|t=ä. Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy |pdf=|usr=}}
Zeile 14: Zeile 17:
 
{{tp|p=32178970|t=2020. Composition of human-specific slow codons and slow di-codons in SARS-CoV and 2019-nCoV are lower than other coronaviruses suggesting a faster protein synthesis rate of SARS-CoV and 2019-nCoV |pdf=|usr=}}
 
{{tp|p=32178970|t=2020. Composition of human-specific slow codons and slow di-codons in SARS-CoV and 2019-nCoV are lower than other coronaviruses suggesting a faster protein synthesis rate of SARS-CoV and 2019-nCoV |pdf=|usr=}}
 
{{tp|p=32350227|t=2020. Characteristics of SARS-CoV-2 isolated from asymptomatic carrier in Tokyo |pdf=|usr=}}
 
{{tp|p=32350227|t=2020. Characteristics of SARS-CoV-2 isolated from asymptomatic carrier in Tokyo |pdf=|usr=}}
{{tp|p=32342926|t=2020. Properties of Coronavirus and SARS-CoV-2 |pdf=|usr=}}
+
{{ttp|p=32342926|t=2020. Properties of Coronavirus and SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32194253|t=ä. Molecular basis of COVID-19 relationships in different species: a one health perspective |pdf=|usr=}}
 
{{tp|p=32194253|t=ä. Molecular basis of COVID-19 relationships in different species: a one health perspective |pdf=|usr=}}
{{tp|p=32303698|t=ä. A map of SARS-CoV-2 and host cell interactions |pdf=|usr=}}
 
 
{{tp|p=C7085496|t=ä. Structural, glycosylation and antigenic variation between 2019 novel coronavirus  (2019-nCoV) and SARS coronavirus (SARS-CoV) |pdf=|usr=}}
 
{{tp|p=C7085496|t=ä. Structural, glycosylation and antigenic variation between 2019 novel coronavirus  (2019-nCoV) and SARS coronavirus (SARS-CoV) |pdf=|usr=}}
{{tp|p=32218151|t=2020. Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins |pdf=|usr=}}
+
{{ttp|p=32218151|t=2020. Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins |pdf=|usr=}}
 
{{tp|p=32098422|t=2020. Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV |pdf=|usr=}}
 
{{tp|p=32098422|t=2020. Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV |pdf=|usr=}}
{{tp|p=32348474|t=2020. Expanding our understanding of the role polyprotein conformation plays in the coronavirus life cycle |pdf=|usr=}}
+
{{ttp|p=32348474|t=2020. Expanding our understanding of the role polyprotein conformation plays in the coronavirus life cycle |pdf=|usr=}}
 
{{tp|p=32367648|t=2020. SARS-CoV-2 variants: Relevance for symptom granularity, epidemiology, immunity (herd, vaccines), virus origin and containment?|pdf=|usr=}}
 
{{tp|p=32367648|t=2020. SARS-CoV-2 variants: Relevance for symptom granularity, epidemiology, immunity (herd, vaccines), virus origin and containment?|pdf=|usr=}}
 
{{tp|p=32342578|t=2020. The Importance Of Naturally Attenuated Sars-Cov-2 In The Fight Against Covid-19 |pdf=|usr=}}
 
{{tp|p=32342578|t=2020. The Importance Of Naturally Attenuated Sars-Cov-2 In The Fight Against Covid-19 |pdf=|usr=}}
Zeile 30: Zeile 32:
 
{{tp|p=32452417|t=2020. New insights into the evolutionary features of viral overlapping genes by discriminant analysis |pdf=|usr=}}
 
{{tp|p=32452417|t=2020. New insights into the evolutionary features of viral overlapping genes by discriminant analysis |pdf=|usr=}}
 
{{ttp|p=31916022|t=2020. Cryo-EM Studies of Virus-Antibody Immune Complexes |pdf=|usr=}}
 
{{ttp|p=31916022|t=2020. Cryo-EM Studies of Virus-Antibody Immune Complexes |pdf=|usr=}}
 +
{{tp|p=32558639|t=2020. Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2.|pdf=|usr=010}}
 +
{{tp|p=32592845|t=2020. Comparative analysis of protein synthesis rate in COVID-19 with other human coronaviruses.|pdf=|usr=010}}
 +
{{ttp|p=32579100|t=2020. Insights into SARS-CoV-2, the Coronavirus Underlying COVID-19: Recent Genomic Data and the Development of Reverse Genetics Systems.|pdf=|usr=010}}
 +
{{tp|p=32598499|t=2020. SARS-CoV-2: march toward adaptation.|pdf=|usr=011}}
 +
{{ttp|p=32536162|t=2020. Role of RNA Guanine Quadruplexes in Favoring the Dimerization of SARS Unique Domain in Coronaviruses.|pdf=|usr=011}}
  
  
 
===genome===
 
===genome===
 
*[[Genome announcements]] pure genome data without specific hypothesis
 
*[[Genome announcements]] pure genome data without specific hypothesis
 +
*[[Interkingdom homologies]]
 +
{{ttp|p=32596428|t=2020. Data stream dataset of SARS-CoV-2 genome.|pdf=|usr=011}}
 +
{{tp|p=32543691|t=2020. Genetic Analysis Tracks SARS-CoV-2 Mutations in Human Hosts.|pdf=|usr=011}}
  
 +
{{tp|p=32595352|t=2020. An updated analysis of variations in SARS-CoV-2 genome.|pdf=|usr=011}}
 +
{{tp|p=32595351|t=2020. Phylogenetic analysis of SARS-CoV-2 genomes in Turkey.|pdf=|usr=011}}
 +
{{tp|p=32595958|t=2020. Analyses of spike protein from first deposited sequences of SARS-CoV2 from West Bengal, India.|pdf=|usr=011}}
 +
{{tp|p=32595354|t=2020. Identification of the nucleotide substitutions in 62 SARS-CoV-2 sequences from Turkey.|pdf=|usr=011}}
 +
{{tp|p=32595356|t=2020. SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients.|pdf=|usr=011}}
 +
{{tp|p=32596474|t=2020. Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2.|pdf=|usr=011}}
 +
{{tp|p=32543353|t=2020. SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East.|pdf=|usr=010}}
 +
{{tp|p=32543348|t=2020. Virus strain from a mild COVID-19 patient in Hangzhou represents a new trend in SARS-CoV-2 evolution potentially related to Furin cleavage site.|pdf=|usr=010}}
 +
{{tp|p=32586872|t=2020. Genome Sequence of SARS-CoV-2 Isolate Cali-01, from Colombia, Obtained Using Oxford Nanopore MinION Sequencing.|pdf=|usr=010}}
 +
{{tp|p=32581081|t=2020. Rampant C-->U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories.|pdf=|usr=010}}
 +
{{tp|p=32566234|t=2020. Phyloevolutionary analysis of SARS-CoV-2 in Nigeria.|pdf=|usr=011}}
 +
{{tp|p=32571880|t=2020. Structural and functional conservation of the programmed -1 ribosomal frameshift signal of SARS coronavirus 2 (SARS-CoV-2).|pdf=|usr=011}}
 +
{{ttp|p=32605661|t=2020. Multiple approaches for massively parallel sequencing of SARS-CoV-2 genomes directly from clinical samples.|pdf=|usr=011}}
 +
{{tp|p=32610037|t=2020. Rapid, Sensitive, Full-Genome Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2.|pdf=|usr=011}}
 +
{{tp|p=32556599|t=2020. Full genome sequence of the first SARS-CoV-2 detected in Mexico.|pdf=|usr=010}}
 +
{{tp|p=32512089|t=2020. Corona virus versus existence of human on the earth: A computational and biophysical approach.|pdf=|usr=007}}
 +
{{tp|p=32528156|t=2020. Ten recommendations for supporting open pathogen genomic analysis in public health.|pdf=|usr=008}}
 +
{{tp|p=32509310|t=2020. Severe acute respiratory syndrome coronavirus 2: virus mutations in specific European populations.|pdf=|usr=009}}
 +
{{tp|p=32528815|t=2020. Genome-Wide Identification and Characterization of Point Mutations in the SARS-CoV-2 Genome.|pdf=|usr=009}}
 +
{{tp|p=32431949|t=2020. Multivariate analyses of codon usage of SARS-CoV-2 and other betacoronaviruses.|pdf=|usr=009}}
 +
{{tp|p=32509472|t=2020. Insights on early mutational events in SARS-CoV-2 virus reveal founder effects across geographical regions.|pdf=|usr=009}}
 +
{{ttp|p=32512929|t=2020. The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities.|pdf=|usr=009}}
 +
{{tp|p=32513865|t=2020. Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California.|pdf=|usr=009}}
 +
{{tp|p=32450246|t=2020. Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience.|pdf=|usr=008}}
 +
{{tp|p=32292587|t=2020. Mutated COVID-19, May Foretells Mankind in a Great Risk in the Future.|pdf=|usr=009}}
 +
{{tp|p=32483490|t=2020. The role of selectivity of the SARS-CoV-2 virus for human genetic profiles in susceptibility and resistance to COVID-19.|pdf=|usr=009}}
 +
{{tp|p=32381617|t=2020. Near-Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Causing a COVID-19 Case in Peru.|pdf=|usr=009}}
 +
{{tp|p=32467284|t=2020. Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Egypt.|pdf=|usr=009}}
 +
{{tp|p=32467283|t=2020. Complete Genome Sequence of SARS-CoV-2 in a Tiger from a U.S. Zoological Collection.|pdf=|usr=009}}
 +
{{tp|p=32409547|t=2020. Complete Genome Sequences of SARS-CoV-2 Strains Detected in Malaysia.|pdf=|usr=009}}
 +
{{tp|p=32527780|t=2020. Complete Genome Sequence of a Novel Coronavirus (SARS-CoV-2) Isolate from Bangladesh.|pdf=|usr=009}}
 +
{{tp|p=32528128|t=2020. Bat-borne virus diversity, spillover and emergence.|pdf=|usr=009}}
 +
{{tp|p=32464496|t=2020. Genetic variation in SARS-CoV-2 may explain variable severity of COVID-19.|pdf=|usr=009}}
 +
{{tp|p=32412415|t=2020. A Snapshot of SARS-CoV-2 Genome Availability up to April 2020 and its Implications: Data Analysis.|pdf=|usr=009}}
 
{{tp|p=32398273|t=2020. RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look.|pdf=|usr=007}}
 
{{tp|p=32398273|t=2020. RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look.|pdf=|usr=007}}
{{tp|p=32167180|t=ä. The establishment of reference sequence for SARS?CoV?2 and variation analysis |pdf=|usr=}}
+
{{ttp|p=32330414|t=ä. The Architecture of SARS-CoV-2 Transcriptome |pdf=|usr=}}
{{tp|p=32330414|t=ä. The Architecture of SARS-CoV-2 Transcriptome |pdf=|usr=}}
+
 
{{tp|p=32289263|t=ä. An Infectious cDNA Clone of SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32289263|t=ä. An Infectious cDNA Clone of SARS-CoV-2 |pdf=|usr=}}
 
*[https://www.sciencedirect.com/science/article/pii/S1567134820301829 genomic var. is high]
 
*[https://www.sciencedirect.com/science/article/pii/S1567134820301829 genomic var. is high]
{{tp|p=32007145|t=2020. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding |pdf=|usr=}}
 
{{tp|p=32496247|t=2020. Genome analysis of SARS-CoV-2 isolates occurring in India: Present scenario.|pdf=|usr=007}}
 
{{tp|p=31987001|t=2020. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated  from a patient with atypical pneumonia after visiting Wuhan |pdf=|usr=}}
 
{{tp|p=32269081|t=2020. Phylogenetic network analysis of SARS-CoV-2 genomes |pdf=|usr=}}
 
{{tp|p=32265007|t=2020. Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe |pdf=|usr=}}
 
 
{{ttp|p=32341946|t=2020. Chaos game representation dataset of SARS-CoV-2 genome |pdf=|usr=}}
 
{{ttp|p=32341946|t=2020. Chaos game representation dataset of SARS-CoV-2 genome |pdf=|usr=}}
 
{{tp|p=C7200767|t=2020. Chaos game representation dataset of SARS-CoV-2 genome |pdf=|usr=}}
 
{{tp|p=C7200767|t=2020. Chaos game representation dataset of SARS-CoV-2 genome |pdf=|usr=}}
 
{{tp|p=32301390|t=2020. Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction |pdf=|usr=}}
 
{{tp|p=32301390|t=2020. Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction |pdf=|usr=}}
{{tp|p=32129843|t=ä. Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients |pdf=|usr=}}
 
{{tp|p=32129842|t=ä. A glimpse into the origins of genetic diversity in SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32466577|t=2020. Early Phylogenetic Diversification of SARS-CoV-2: Determination of Variants and the Effect on Epidemiology, Immunology, and Diagnostics.|pdf=|usr=007}}
 
{{tp|p=32169673|t=2020. Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species |pdf=|usr=}}
 
{{tp|p=32349035|t=2020. Genomic Analysis and Comparative Multiple Sequence of SARS-CoV2 |pdf=|usr=}}
 
{{tp|p=32222995|t=ä. Phylogenetic analysis of the first four SARS?CoV?2 cases in Chile |pdf=|usr=}}
 
 
{{tp|p=32167166|t=ä. An exclusive 42 amino acid signature in pp1ab protein provides insights into the  evolutive history of the 2019 novel human?pathogenic coronavirus (SARS?CoV?2) |pdf=|usr=}}
 
{{tp|p=32167166|t=ä. An exclusive 42 amino acid signature in pp1ab protein provides insights into the  evolutive history of the 2019 novel human?pathogenic coronavirus (SARS?CoV?2) |pdf=|usr=}}
{{tp|p=32149036|t=2020. Identification of Coronavirus Isolated from a Patient in Korea with COVID-19 |pdf=|usr=}}
 
{{tp|p=32357545|t=2020. Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody Treatment |pdf=|usr=}}
 
{{tp|p=32242873|t=2020. Full-genome sequences of the first two SARS-CoV-2 viruses from India |pdf=|usr=}}
 
{{tp|p=32351056|t=2020. Decoding the evolution and transmissions of the novel pneumonia coronavirus (SARS-CoV-2 / HCoV-19) using whole genomic data |pdf=|usr=}}
 
{{tp|p=32092483|t=2020. Genetic diversity and evolution of SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32335334|t=ä. Emerging genetic diversity among clinical isolates of SARS-CoV-2: Lessons for today |pdf=|usr=}}
 
{{tp|p=32171191|t=2020.  Genomic analysis of a 2019-novel coronavirus (2019-nCoV) strain in the first COVID-19 patient found in Hangzhou  |pdf=|usr=}}
 
{{tp|p=32238585|t=2020. Isolation and Full-Length Genome Characterization of SARS-CoV-2 from COVID-19 Cases in Northern Italy |pdf=|usr=}}
 
{{tp|p=32238584|t=2020. Computational inference of selection underlying the evolution of the novel coronavirus, SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32314811|t=2020. Understanding evolution of SARS-CoV-2: a perspective from analysis of genetic diversity of RdRp gene |pdf=|usr=}}
 
{{tp|p=32311094|t=2020. Distinct Viral Clades of SARS-CoV-2: Implications for Modeling of Viral Spread |pdf=|usr=}}
 
{{tp|p=32165386|t=2020. Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal |pdf=|usr=}}
 
 
{{tp|p=32145215|t=ä. Identification of the hyper-variable genomic hotspot for the novel coronavirus SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32145215|t=ä. Identification of the hyper-variable genomic hotspot for the novel coronavirus SARS-CoV-2 |pdf=|usr=}}
{{tp|p=31994738|t=2020. The 2019?new coronavirus epidemic: Evidence for virus evolution |pdf=|usr=}}
 
{{tp|p=32027036|t=2020. Genomic variance of the 2019?nCoV coronavirus |pdf=|usr=}}
 
{{tp|p=32004758|t=2020. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event |pdf=|usr=}}
 
{{tp|p=32300673|t=2020. Genomic characterization of a novel SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32353474|t=ä. Genotyping coronavirus SARS-CoV-2: Methods and implications |pdf=|usr=}}
 
{{tp|p=32362650|t=2020. Genomic analysis of SARS-CoV-2 strains among Indians returning from Italy, Iran & China, & Italian tourists in India |pdf=|usr=}}
 
{{tp|p=32387564|t=2020. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2 |pdf=|usr=}}
 
 
{{tp|p=32471829|t=2020. Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS-CoV-2-Related Viruses.|pdf=|usr=007}}
 
{{tp|p=32471829|t=2020. Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS-CoV-2-Related Viruses.|pdf=|usr=007}}
{{tp|p=32288962|t=2020. Evolutionary perspectives on novel coronaviruses identified in pneumonia cases in China |pdf=|usr=}}
 
{{tp|p=C7107875|t=ä. On the origin and continuing evolution of SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=C7197565|t=ä. No evidence for distinct types in the evolution of SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32499358|t=2020. Complete Genome Sequence of a SARS-CoV-2 Strain Isolated in Northern Germany.|pdf=|usr=007}}
 
 
{{tp|p=32437232|t=2020. Virus-induced genetics revealed by multidimensional precision medicine transcriptional workflow applicable to COVID-19.|pdf=|usr=007}}
 
{{tp|p=32437232|t=2020. Virus-induced genetics revealed by multidimensional precision medicine transcriptional workflow applicable to COVID-19.|pdf=|usr=007}}
{{tp|p=32439706|t=2020. Reply to Sanchez-Pacheco et al., Chookajorn, and Mavian et al.: Explaining phylogenetic network analysis of SARS-CoV-2 genomes.|pdf=|usr=007}}
 
 
{{tp|p=32422894|t=2020. A Novel Synonymous Mutation of SARS-CoV-2: Is This Possible to Affect Their Antigenicity and Immunogenicity?|pdf=|usr=007}}
 
{{tp|p=32422894|t=2020. A Novel Synonymous Mutation of SARS-CoV-2: Is This Possible to Affect Their Antigenicity and Immunogenicity?|pdf=|usr=007}}
{{tp|p=32506536|t=2020. Emerging viral mutants in Australia suggest RNA recombination event in the SARS-CoV-2 genome.|pdf=|usr=007}}
 
{{tp|p=32459984|t=2020. SARS-CoV-2 Phylogenetic Analysis, Lazio Region, Italy, February-March 2020.|pdf=|usr=007}}
 
{{tp|p=32462705|t=2020. Clinical features, isolation, and complete genome sequence of severe acute respiratory syndrome coronavirus 2 from the first two patients in Vietnam.|pdf=|usr=007}}
 
 
{{ttp|p=32484220|t=2020. Discovery of G-quadruplex-forming sequences in SARS-CoV-2.|pdf=|usr=007}}
 
{{ttp|p=32484220|t=2020. Discovery of G-quadruplex-forming sequences in SARS-CoV-2.|pdf=|usr=007}}
 
{{tp|p=32472763|t=2020. Comparative analysis of Coronaviridae nucleocapsid and surface glycoprotein sequences.|pdf=|usr=007}}
 
{{tp|p=32472763|t=2020. Comparative analysis of Coronaviridae nucleocapsid and surface glycoprotein sequences.|pdf=|usr=007}}
{{tp|p=32503822|t=2020. Human Gene Sequences in SARS-CoV-2 and Other Viruses.|pdf=|usr=007}}
 
{{tp|p=32503821|t=2020. SARS-CoV-2 orf1b Gene Sequence in the NTNG1 Gene on Human Chromosome 1.|pdf=|usr=007}}
 
{{tp|p=32474554|t=2020. Mapping the genomic landscape & diversity of COVID-19 based on >3950 clinical isolates of SARS-CoV-2: Likely origin & transmission dynamics of isolates sequenced in India.|pdf=|usr=007}}
 
 
{{tp|p=32474553|t=2020. Analysis of RNA sequences of 3636 SARS-CoV-2 collected from 55 countries reveals selective sweep of one virus type.|pdf=|usr=007}}
 
{{tp|p=32474553|t=2020. Analysis of RNA sequences of 3636 SARS-CoV-2 collected from 55 countries reveals selective sweep of one virus type.|pdf=|usr=007}}
{{tp|p=32485332|t=2020. SARS-CoV-2 Molecular and Phylogenetic analysis in COVID-19 patients: A preliminary report from Iran.|pdf=|usr=007}}
 
{{tp|p=32497295|t=2020. Comment on "Genetic variants and source of introduction of SARS-CoV-2 in South America".|pdf=|usr=007}}
 
{{tp|p=32492206|t=2020. Understanding the possible origin and genotyping of first Bangladeshi SARS-CoV-2 strain.|pdf=|usr=007}}
 
 
{{tp|p=32492196|t=2020. High-Coverage SARS-CoV-2 Genome Sequences Acquired by Target Capture Sequencing.|pdf=|usr=007}}
 
{{tp|p=32492196|t=2020. High-Coverage SARS-CoV-2 Genome Sequences Acquired by Target Capture Sequencing.|pdf=|usr=007}}
 
{{tp|p=32492183|t=2020. Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission.|pdf=|usr=007}}
 
{{tp|p=32492183|t=2020. Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission.|pdf=|usr=007}}
 
{{ttp|p=32420944|t=2020. The impact of MicroRNAs (miRNAs) on the genotype of coronaviruses.|pdf=|usr=007}}
 
{{ttp|p=32420944|t=2020. The impact of MicroRNAs (miRNAs) on the genotype of coronaviruses.|pdf=|usr=007}}
{{tp|p=32222993|t=ä. Genomic characterization and phylogenetic analysis of SARS?COV?2 in Italy |pdf=|usr=}}
 
{{tp|p=32515358|t=2020. Mutations in SARS-CoV-2 viral RNA identified in Eastern India: Possible implications for the ongoing outbreak in India and impact on viral structure and host susceptibility.|pdf=|usr=008}}
 
 
{{ttp|p=32425659|t=2020. Investigating the genomic landscape of novel coronavirus (2019-nCoV) to identify non-synonymous mutations for use in diagnosis and drug design.|pdf=|usr=008}}
 
{{ttp|p=32425659|t=2020. Investigating the genomic landscape of novel coronavirus (2019-nCoV) to identify non-synonymous mutations for use in diagnosis and drug design.|pdf=|usr=008}}
{{tp|p=32417310|t=2020. Characterization of eight novel full-length genomes of SARS-CoV-2 among imported COVID-19 cases from abroad in Yunnan, China.|pdf=|usr=008}}
 
{{tp|p=32410229|t=2020. Evidence of Increasing Diversification of Emerging SARS-CoV-2 Strains.|pdf=|usr=008}}
 
{{tp|p=32401345|t=2020. Genetic variants and source of introduction of SARS-CoV-2 in South America.|pdf=|usr=008}}
 
 
{{ttp|p=32522874|t=2020. Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses.|pdf=|usr=008}}
 
{{ttp|p=32522874|t=2020. Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses.|pdf=|usr=008}}
 
{{tp|p=32416074|t=2020. A Novel Bat Coronavirus Closely Related to SARS-CoV-2 Contains Natural Insertions at the S1/S2 Cleavage Site of the Spike Protein.|pdf=|usr=008}}
 
{{tp|p=32416074|t=2020. A Novel Bat Coronavirus Closely Related to SARS-CoV-2 Contains Natural Insertions at the S1/S2 Cleavage Site of the Spike Protein.|pdf=|usr=008}}
 
{{tp|p=32525765|t=2020. Genetic cluster analysis of SARS-CoV-2 and the identification of those responsible for the major outbreaks in various countries.|pdf=|usr=008}}
 
{{tp|p=32525765|t=2020. Genetic cluster analysis of SARS-CoV-2 and the identification of those responsible for the major outbreaks in various countries.|pdf=|usr=008}}
 
{{tp|p=32524946|t=2020. Genetic structure of SARS-CoV-2 reflects clonal superspreading and multiple independent introduction events, North-Rhine Westphalia, Germany, February and March 2020.|pdf=|usr=008}}
 
{{tp|p=32524946|t=2020. Genetic structure of SARS-CoV-2 reflects clonal superspreading and multiple independent introduction events, North-Rhine Westphalia, Germany, February and March 2020.|pdf=|usr=008}}
{{tp|p=32445924|t=2020. Overwhelming mutations or SNPs of SARS-CoV-2: A point of caution.|pdf=|usr=008}}
 
{{ttp|p=32522249|t=2020. Genomics of COVID-19: molecular mechanisms going from susceptibility to severity of the disease.|pdf=|usr=008}}
 
{{tp|p=32534867|t=2020. Sequence homology between human PARP14 and the SARS-CoV-2 ADP ribose 1'-phosphatase.|pdf=|usr=008}}
 
 
{{ttp|p=32473977|t=2020. Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation.|pdf=|usr=008}}
 
{{ttp|p=32473977|t=2020. Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation.|pdf=|usr=008}}
{{tp|p=32473976|t=2020. SARS-CoV-2 and COVID-19: A genetic, epidemiological, and evolutionary perspective.|pdf=|usr=008}}
 
 
{{tp|p=32501423|t=2020. Developing an ultra-efficient microsatellite discoverer to find structural differences between SARS-CoV-1 and Covid-19.|pdf=|usr=008}}
 
{{tp|p=32501423|t=2020. Developing an ultra-efficient microsatellite discoverer to find structural differences between SARS-CoV-1 and Covid-19.|pdf=|usr=008}}
{{tp|p=32159234|t=2020. Identification of coronavirus sequences in carp cDNA from Wuhan, China.|pdf=|usr=008}}
 
  
 
===structure===
 
===structure===
 
{{tp|p=32092911|t=2020. Rigidity of the Outer Shell Predicted by a Protein Intrinsic Disorder Model Sheds Light on the COVID-19 (Wuhan-2019-nCoV) Infectivity |pdf=|usr=}}
 
{{tp|p=32092911|t=2020. Rigidity of the Outer Shell Predicted by a Protein Intrinsic Disorder Model Sheds Light on the COVID-19 (Wuhan-2019-nCoV) Infectivity |pdf=|usr=}}
{{tp|p=32362648|t=2020. Transmission electron microscopy imaging of SARS-CoV-2 |pdf=|usr=}}
+
{{ttp|p=32362648|t=2020. Transmission electron microscopy imaging of SARS-CoV-2 |pdf=|usr=}}
{{tp|p=32361692|t=2020. How the COVID-19 Overcomes the Battle? An Approach to Virus Structure |pdf=|usr=}}
+
 
{{tp|p=32292212|t=2020. Photopolarimetrical properties of coronavirus model particles: Spike proteins number influence |pdf=|usr=}}
 
{{tp|p=32292212|t=2020. Photopolarimetrical properties of coronavirus model particles: Spike proteins number influence |pdf=|usr=}}
{{ttp|p=32470119|t=2020. Coronavirus3D: 3D structural visualization of COVID-19 genomic divergence.|pdf=|usr=007}}
+
{{tp|p=32470119|t=2020. Coronavirus3D: 3D structural visualization of COVID-19 genomic divergence.|pdf=|usr=007}}
{{tp|p=32493627|t=2020. Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2.|pdf=|usr=008}}
+
{{ttp|p=32493627|t=2020. Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2.|pdf=|usr=008}}
 +
{{ttp|p=32446936|t=2020. Electron Microscopic Investigations in COVID-19: Not all Crowns Are Coronas.|pdf=|usr=009}}''renal virus-like structures are normal cell constituents''
 +
{{tp|p=32442529|t=2020. Electron microscopy of SARS-CoV-2: a challenging task.|pdf=|usr=009}}''img of read viral particles''
 +
{{tp|p=32442527|t=2020. Electron microscopy of SARS-CoV-2: a challenging task - Authors' reply.|pdf=|usr=009}}
 +
{{tp|p=32455617|t=2020. Novel Dynamic Structures of 2019-nCoV with Nonlocal Operator via Powerful Computational Technique.|pdf=|usr=007}}
 +
{{tp|p=32470223|t=2020. COVID-19: Structural Predictions of Viral Success.|pdf=|usr=007}}
  
 +
 +
===all the proteins===
 +
{{ttp|p=32447571|t=2020. The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19.|pdf=|usr=009}}
 +
{{tp|p=32462744|t=2020. Shortlisting SARS-CoV-2 Peptides for Targeted Studies from Experimental Data-Dependent Acquisition Tandem Mass Spectrometry Data.|pdf=|usr=009}}
 +
{{tp|p=32083638|t=2020. Processing of the SARS-CoV pp1a/ab nsp7-10 region.|pdf=|usr=011}}
 +
{{tp|p=32596311|t=2020. Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics?|pdf=|usr=011}}
 +
{{tp|p=32604797|t=2020. Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1.|pdf=|usr=011}}
 +
 +
===primase complex===
 +
{{ttp|p=32535228|t=2020. Structural analysis of the putative SARS-CoV-2 primase complex.|pdf=|usr=009}}
  
 
===nsp===
 
===nsp===
Zeile 130: Zeile 133:
  
 
===nsp1 protein===
 
===nsp1 protein===
{{tp|p=32336957|t=2020. Combination of Biodata Mining and Computational Modelling in Identification and Characterization of ORF1ab Polyprotein of SARS-CoV-2 Isolated from Oronasopharynx of an Iranian Patient |pdf=|usr=}}
+
 
 +
{{qt|PHA SCR nsp1}}
  
 
===nsp2 protein===
 
===nsp2 protein===
{{tp|p=32083328|t=ä. COVID?2019: The role of the nsp2 and nsp3 in its pathogenesis |pdf=|usr=}}
+
{{qt|PHA SCR nsp2}}
  
 
===nsp3 protein===
 
===nsp3 protein===
{{tp|p=32083328|t=ä. COVID?2019: The role of the nsp2 and nsp3 in its pathogenesis |pdf=|usr=}}
+
{{qt|PHA SCR nsp3}}
{{tp|p=29128390|t=2018. Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein |pdf=|usr=}}
+
  
 
===nsp6 protein===
 
===nsp6 protein===
{{tp|p=32283146|t=2020. Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy.|pdf=|usr=008}}
+
 
 +
{{qt|PHA SCR nsp6}}
 +
 
 +
===nsp7b===
 +
{{tp|p=32142938|t=2020. Nonstructural proteins NS7b and NS8 are likely to be phylogenetically associated  with evolution of 2019-nCoV |pdf=|usr=}}
 +
 
 +
===nsp8===
 +
{{tp|p=32142938|t=2020. Nonstructural proteins NS7b and NS8 are likely to be phylogenetically associated  with evolution of 2019-nCoV |pdf=|usr=}}
 +
 
 +
===nsp9===
 +
{{tp|p=32592996|t=2020. Crystal Structure of the SARS-CoV-2 Non-structural Protein 9, Nsp9.|pdf=|usr=011}}
 +
 
 +
===nsp10, nsp16 methyltransferase===
 +
{{qt|PHA SCR nsp10 nsp16 methyltransferase}}
 +
 
 +
===nsp13 protein NTPase, RNA helicase===
 +
{{qt|PHA SCR nsp13 helicase, nucleotidase}}
 +
 
 +
===nsp14===
 +
{{qt|PHA SCR nsp14}}
  
 
===nsp15 endoribonuclease NendoU===
 
===nsp15 endoribonuclease NendoU===
{{tp|p=32304108|t=2020. Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2 |pdf=|usr=}}
 
  
===papain-like proteinase 2===
+
{{qt|PHA SCR nsp15 endoribonuclease}}
{{tp|p=32216114|t=ä. Structural and biochemical characterization of SARS-CoV papain-like protease 2 |pdf=|usr=}}
+
  
===replication factors===
+
===papain-like proteinase===
{{tp|p=32321524|t=2020. Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant |pdf=|usr=}}
+
{{qt|PHA SCR papain-like proteinase}}
{{tp|p=32277040|t=2020. Structure of the RNA-dependent RNA polymerase from COVID-19 virus |pdf=|usr=}}
+
{{tp|p=32167173|t=ä. The potential chemical structure of anti?SARS?CoV?2 RNA?dependent RNA polymerase |pdf=|usr=}}
+
{{ttp|p=32511245|t=2020. A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis.|pdf=|usr=007}}
+
{{tp|p=32438371|t=2020. Structure of replicating SARS-CoV-2 polymerase.|pdf=|usr=007}}
+
{{tp|p=32443810|t=2020. A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping.|pdf=|usr=007}}
+
{{tp|p=32427393|t=2020. Telomeres and COVID-19.|pdf=|usr=007}}
+
{{tp|p=32392072|t=2020. Novel Coronavirus Polymerase and Nucleotidyl-Transferase Structures: Potential to Target New Outbreaks.|pdf=|usr=008}}
+
{{tp|p=32526208|t=2020. Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase.|pdf=|usr=008}}
+
{{tp|p=32531208|t=2020. Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2.|pdf=|usr=008}}
+
  
 +
===replication factors, nsp12, nsp8, nsp7===
 +
{{qt|PHA SCR rna-dependent rna-polymerase}}
  
 
===nucleocapsid===
 
===nucleocapsid===
Zeile 166: Zeile 179:
 
{{tp|p=32416961|t=2020. Biochemical characterization of SARS-CoV-2 nucleocapsid protein |pdf=|usr=}}
 
{{tp|p=32416961|t=2020. Biochemical characterization of SARS-CoV-2 nucleocapsid protein |pdf=|usr=}}
 
{{ttp|p=32291557|t=ä. SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells |pdf=|usr=}}
 
{{ttp|p=32291557|t=ä. SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells |pdf=|usr=}}
 +
{{ttp|p=32562316|t=2020. A proposed role for the SARS-CoV-2 nucleocapsid protein in the formation and regulation of biomolecular condensates.|pdf=|usr=010}}
 +
{{ttp|p=32589897|t=2020. The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway.|pdf=|usr=011}}
 +
  
  
Zeile 177: Zeile 193:
  
 
'''envelope'''
 
'''envelope'''
 +
{{tp|p=32446902|t=2020. Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19.|pdf=|usr=009}}
 +
 +
 +
===receptor binding any target===
 +
{{ttp|p=32565603|t=2020. Update on the target structures of SARS-CoV-2: A systematic review.|pdf=|usr=011}}
 +
{{tp|p=32604730|t=2020. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.|pdf=|usr=011}}
 +
{{tp|p=32595513|t=2020. New Strategy for COVID-19: An Evolutionary Role for RGD Motif in SARS-CoV-2 and Potential Inhibitors for Virus Infection.|pdf=|usr=011}}
  
 
*'''[[Target ACE2, Spike protein]]'''
 
*'''[[Target ACE2, Spike protein]]'''
  
 
===receptor binding: trmpss2===
 
===receptor binding: trmpss2===
{{tp|p=32165541|t=2020. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells |pdf=|usr=}}
+
{{qt|PHA SCR spike protein TMPRSS2}}
{{tp|p=32404436|t=2020. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes.|pdf=|usr=007}}
+
{{tp|p=32410502|t=2020. First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations.|pdf=|usr=007}}
+
{{tp|p=32437018|t=2020. TMPRSS2: Potential Biomarker for COVID-19 Outcomes.|pdf=|usr=007}}
+
{{tp|p=32468052|t=2020. Pancancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARSCoV2 infection leading to COVID-19.|pdf=|usr=007}}
+
 
+
  
 
===receptor binding: trmpss4===
 
===receptor binding: trmpss4===
{{tp|p=32404436|t=2020. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes.|pdf=|usr=007}}
+
{{qt|PHA SCR spike protein TMPRSS4}}
  
 
===receptor binding: grp78, g-proteins===
 
===receptor binding: grp78, g-proteins===
{{ttp|p=32169481|t=2020. COVID-19 spike-host cell receptor GRP78 binding site prediction |pdf=|usr=}}
+
{{qt|PHA SRC spike protein Grp78}}
{{tp|p=32329083|t=2020. (ang.)COVID-19 transmission through host cell directed network of GPCR |pdf=|usr=}}
+
  
 
===candidate receptor binding DPP4===
 
===candidate receptor binding DPP4===
Zeile 199: Zeile 216:
  
 
===Uptake: cathepsin L===
 
===Uptake: cathepsin L===
{{tp|p=32468052|t=2020. Pancancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARSCoV2 infection leading to COVID-19.|pdf=|usr=007}}
+
{{qt|PHA SCR spike protein Cathepsin L}}
  
 
===endocytosis membrane fusion===
 
===endocytosis membrane fusion===
Zeile 206: Zeile 223:
 
{{tp|p=32130973|t=2020. A potential role for integrins in host cell entry by SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32130973|t=2020. A potential role for integrins in host cell entry by SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32246503|t=ä. SARS?COV?2 and infectivity: Possible increase in infectivity associated to integrin motif expression |pdf=|usr=}}
 
{{tp|p=32246503|t=ä. SARS?COV?2 and infectivity: Possible increase in infectivity associated to integrin motif expression |pdf=|usr=}}
{{tp|p=32272173|t=2020. Coronavirus membrane fusion mechanism offers a potential target for antiviral development |pdf=|usr=}}
+
{{ttp|p=32272173|t=2020. Coronavirus membrane fusion mechanism offers a potential target for antiviral development |pdf=|usr=}}
 
{{tp|p=32094589|t=ä. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses |pdf=|usr=}}
 
{{tp|p=32094589|t=ä. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses |pdf=|usr=}}
 
{{ttp|p=32376634|t=2020. Cell entry mechanisms of SARS-CoV-2 |pdf=|usr=}}
 
{{ttp|p=32376634|t=2020. Cell entry mechanisms of SARS-CoV-2 |pdf=|usr=}}
Zeile 215: Zeile 232:
  
 
===3CL proteinase and main proteinase is the same===
 
===3CL proteinase and main proteinase is the same===
{{tp|p=32293875|t=ä. Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms |pdf=|usr=}}
+
{{qt|PHA SCR main protease}}
{{tp|p=32239142|t=ä. Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus |pdf=|usr=}}
+
{{tp|p=32308266|t=2020. Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus |pdf=|usr=}}
+
{{tp|p=32313296|t=2020. Identification of potential binders of the ''main protease 3CLpro'' of the COVID-19 via structure-based ligand design and molecular modeling |pdf=|usr=}}
+
{{tp|p=32391184|t=2020. Comprehensive Insights into the Catalytic Mechanism of Middle East Respiratory Syndrome 3C-Like Protease and Severe Acute Respiratory Syndrome 3C-Like Protease |pdf=|usr=}}
+
{{tp|p=32210741|t=2020. Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target |pdf=|usr=}}
+
{{tp|p=32194944|t=2020. Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates |pdf=|usr=}}
+
  
 
===orf===
 
===orf===
Zeile 227: Zeile 238:
 
{{tp|p=32371472|t=2020. SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis |pdf=|usr=}}
 
{{tp|p=32371472|t=2020. SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis |pdf=|usr=}}
 
{{tp|p=32433742|t=2020. Extended ORF8 Gene Region Is Valuable in the Epidemiological Investigation of SARS-similar Coronavirus.|pdf=|usr=007}}
 
{{tp|p=32433742|t=2020. Extended ORF8 Gene Region Is Valuable in the Epidemiological Investigation of SARS-similar Coronavirus.|pdf=|usr=007}}
 +
{{tp|p=32555321|t=2020. The ORF3a protein of SARS-CoV-2 induces apoptosis in cells.|pdf=|usr=010}}
 +
{{tp|p=32589897|t=2020. The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway.|pdf=|usr=011}}
 +
{{tp|p=32540495|t=2020. Molecular conservation and differential mutation on ORF3a gene in Indian SARS-CoV2 genomes.|pdf=|usr=011}}
 +
{{tp|p=32504060|t=2020. Immune evasion via SARS-CoV-2 ORF8 protein?|pdf=|usr=009}}
 +
  
  
Zeile 238: Zeile 254:
 
{{tp|p=32291894|t=2020. Cytosine drives evolution of SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32291894|t=2020. Cytosine drives evolution of SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32159237|t=ä. From SARS and MERS CoVs to SARS?CoV?2: Moving toward more biased codon usage in viral structural and nonstructural genes |pdf=|usr=}}
 
{{tp|p=32159237|t=ä. From SARS and MERS CoVs to SARS?CoV?2: Moving toward more biased codon usage in viral structural and nonstructural genes |pdf=|usr=}}
{{tp|p=C7181939|t=2020. Etymologia: Coronavirus |pdf=|usr=}}
 
 
{{tp|p=32387562|t=2020. Coding potential and sequence conservation of SARS-CoV-2 and related animal viruses |pdf=|usr=}}
 
{{tp|p=32387562|t=2020. Coding potential and sequence conservation of SARS-CoV-2 and related animal viruses |pdf=|usr=}}
 
{{tp|p=32294518|t=2020. A comprehensive analysis of genome composition and codon usage patterns of emerging coronaviruses |pdf=|usr=}}
 
{{tp|p=32294518|t=2020. A comprehensive analysis of genome composition and codon usage patterns of emerging coronaviruses |pdf=|usr=}}

Aktuelle Version vom 27. April 2021, 17:04 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

 I further streaming-in related content is here

major items will be recollected into the pharmacophore section

PHA pharmacophore by screened target

integrative papers

32507543 2020. Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2.


32181901 ä. A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019?nCoV)
32296735 2020. Prudently conduct the engineering and synthesis of the SARS-CoV-2 virus
C7085496 ä. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)
32254054 2020. Visualizing an unseen enemy; mobilizing structural biology to counter COVID-191
32311462 2020. On the molecular determinants of the SARS-CoV-2 attack
32229288 ä. Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy
32306836 2020. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment
32265180 ä. Genotype and phenotype of COVID-19: Their roles in pathogenesis
32178970 2020. Composition of human-specific slow codons and slow di-codons in SARS-CoV and 2019-nCoV are lower than other coronaviruses suggesting a faster protein synthesis rate of SARS-CoV and 2019-nCoV
32350227 2020. Characteristics of SARS-CoV-2 isolated from asymptomatic carrier in Tokyo

32342926 2020. Properties of Coronavirus and SARS-CoV-2


32194253 ä. Molecular basis of COVID-19 relationships in different species: a one health perspective
C7085496 ä. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)

32218151 2020. Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins


32098422 2020. Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV

32348474 2020. Expanding our understanding of the role polyprotein conformation plays in the coronavirus life cycle


32367648 2020. SARS-CoV-2 variants: Relevance for symptom granularity, epidemiology, immunity (herd, vaccines), virus origin and containment?
32342578 2020. The Importance Of Naturally Attenuated Sars-Cov-2 In The Fight Against Covid-19
32104911 ä. Evolutionary history, potential intermediate animal host, and cross?species analyses of SARS?CoV?2
32365353 2020. Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform
32092385 2020. The continuous evolution and dissemination of 2019 novel human coronavirus
32361530 2020. The puzzle of sharing bio-molecular targets between coronaviruses and mediators of the cardiovascular system in humans: Looking for plausible hypotheses
32402329 2020. Novel human coronavirus (SARS-CoV-2): A lesson from animal coronaviruses
32452417 2020. New insights into the evolutionary features of viral overlapping genes by discriminant analysis

31916022 2020. Cryo-EM Studies of Virus-Antibody Immune Complexes


32558639 2020. Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2.
32592845 2020. Comparative analysis of protein synthesis rate in COVID-19 with other human coronaviruses.

32579100 2020. Insights into SARS-CoV-2, the Coronavirus Underlying COVID-19: Recent Genomic Data and the Development of Reverse Genetics Systems.


32598499 2020. SARS-CoV-2: march toward adaptation.

32536162 2020. Role of RNA Guanine Quadruplexes in Favoring the Dimerization of SARS Unique Domain in Coronaviruses.


genome

32596428 2020. Data stream dataset of SARS-CoV-2 genome.


32543691 2020. Genetic Analysis Tracks SARS-CoV-2 Mutations in Human Hosts.


32595352 2020. An updated analysis of variations in SARS-CoV-2 genome.
32595351 2020. Phylogenetic analysis of SARS-CoV-2 genomes in Turkey.
32595958 2020. Analyses of spike protein from first deposited sequences of SARS-CoV2 from West Bengal, India.
32595354 2020. Identification of the nucleotide substitutions in 62 SARS-CoV-2 sequences from Turkey.
32595356 2020. SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients.
32596474 2020. Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2.
32543353 2020. SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East.
32543348 2020. Virus strain from a mild COVID-19 patient in Hangzhou represents a new trend in SARS-CoV-2 evolution potentially related to Furin cleavage site.
32586872 2020. Genome Sequence of SARS-CoV-2 Isolate Cali-01, from Colombia, Obtained Using Oxford Nanopore MinION Sequencing.
32581081 2020. Rampant C-->U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories.
32566234 2020. Phyloevolutionary analysis of SARS-CoV-2 in Nigeria.
32571880 2020. Structural and functional conservation of the programmed -1 ribosomal frameshift signal of SARS coronavirus 2 (SARS-CoV-2).

32605661 2020. Multiple approaches for massively parallel sequencing of SARS-CoV-2 genomes directly from clinical samples.


32610037 2020. Rapid, Sensitive, Full-Genome Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2.
32556599 2020. Full genome sequence of the first SARS-CoV-2 detected in Mexico.
32512089 2020. Corona virus versus existence of human on the earth: A computational and biophysical approach.
32528156 2020. Ten recommendations for supporting open pathogen genomic analysis in public health.
32509310 2020. Severe acute respiratory syndrome coronavirus 2: virus mutations in specific European populations.
32528815 2020. Genome-Wide Identification and Characterization of Point Mutations in the SARS-CoV-2 Genome.
32431949 2020. Multivariate analyses of codon usage of SARS-CoV-2 and other betacoronaviruses.
32509472 2020. Insights on early mutational events in SARS-CoV-2 virus reveal founder effects across geographical regions.

32512929 2020. The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities.


32513865 2020. Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California.
32450246 2020. Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience.
32292587 2020. Mutated COVID-19, May Foretells Mankind in a Great Risk in the Future.
32483490 2020. The role of selectivity of the SARS-CoV-2 virus for human genetic profiles in susceptibility and resistance to COVID-19.
32381617 2020. Near-Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Causing a COVID-19 Case in Peru.
32467284 2020. Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Egypt.
32467283 2020. Complete Genome Sequence of SARS-CoV-2 in a Tiger from a U.S. Zoological Collection.
32409547 2020. Complete Genome Sequences of SARS-CoV-2 Strains Detected in Malaysia.
32527780 2020. Complete Genome Sequence of a Novel Coronavirus (SARS-CoV-2) Isolate from Bangladesh.
32528128 2020. Bat-borne virus diversity, spillover and emergence.
32464496 2020. Genetic variation in SARS-CoV-2 may explain variable severity of COVID-19.
32412415 2020. A Snapshot of SARS-CoV-2 Genome Availability up to April 2020 and its Implications: Data Analysis.
32398273 2020. RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look.

32330414 ä. The Architecture of SARS-CoV-2 Transcriptome


32289263 ä. An Infectious cDNA Clone of SARS-CoV-2

32341946 2020. Chaos game representation dataset of SARS-CoV-2 genome


C7200767 2020. Chaos game representation dataset of SARS-CoV-2 genome
32301390 2020. Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction
32167166 ä. An exclusive 42 amino acid signature in pp1ab protein provides insights into the evolutive history of the 2019 novel human?pathogenic coronavirus (SARS?CoV?2)
32145215 ä. Identification of the hyper-variable genomic hotspot for the novel coronavirus SARS-CoV-2
32471829 2020. Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS-CoV-2-Related Viruses.
32437232 2020. Virus-induced genetics revealed by multidimensional precision medicine transcriptional workflow applicable to COVID-19.
32422894 2020. A Novel Synonymous Mutation of SARS-CoV-2: Is This Possible to Affect Their Antigenicity and Immunogenicity?

32484220 2020. Discovery of G-quadruplex-forming sequences in SARS-CoV-2.


32472763 2020. Comparative analysis of Coronaviridae nucleocapsid and surface glycoprotein sequences.
32474553 2020. Analysis of RNA sequences of 3636 SARS-CoV-2 collected from 55 countries reveals selective sweep of one virus type.
32492196 2020. High-Coverage SARS-CoV-2 Genome Sequences Acquired by Target Capture Sequencing.
32492183 2020. Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission.

32420944 2020. The impact of MicroRNAs (miRNAs) on the genotype of coronaviruses.
32425659 2020. Investigating the genomic landscape of novel coronavirus (2019-nCoV) to identify non-synonymous mutations for use in diagnosis and drug design.
32522874 2020. Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses.


32416074 2020. A Novel Bat Coronavirus Closely Related to SARS-CoV-2 Contains Natural Insertions at the S1/S2 Cleavage Site of the Spike Protein.
32525765 2020. Genetic cluster analysis of SARS-CoV-2 and the identification of those responsible for the major outbreaks in various countries.
32524946 2020. Genetic structure of SARS-CoV-2 reflects clonal superspreading and multiple independent introduction events, North-Rhine Westphalia, Germany, February and March 2020.

32473977 2020. Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation.


32501423 2020. Developing an ultra-efficient microsatellite discoverer to find structural differences between SARS-CoV-1 and Covid-19.

structure


32092911 2020. Rigidity of the Outer Shell Predicted by a Protein Intrinsic Disorder Model Sheds Light on the COVID-19 (Wuhan-2019-nCoV) Infectivity

32362648 2020. Transmission electron microscopy imaging of SARS-CoV-2


32292212 2020. Photopolarimetrical properties of coronavirus model particles: Spike proteins number influence
32470119 2020. Coronavirus3D: 3D structural visualization of COVID-19 genomic divergence.

32493627 2020. Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2.
32446936 2020. Electron Microscopic Investigations in COVID-19: Not all Crowns Are Coronas.
renal virus-like structures are normal cell constituents


32442529 2020. Electron microscopy of SARS-CoV-2: a challenging task. img of read viral particles
32442527 2020. Electron microscopy of SARS-CoV-2: a challenging task - Authors' reply.
32455617 2020. Novel Dynamic Structures of 2019-nCoV with Nonlocal Operator via Powerful Computational Technique.
32470223 2020. COVID-19: Structural Predictions of Viral Success.


all the proteins

32447571 2020. The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19.


32462744 2020. Shortlisting SARS-CoV-2 Peptides for Targeted Studies from Experimental Data-Dependent Acquisition Tandem Mass Spectrometry Data.
32083638 2020. Processing of the SARS-CoV pp1a/ab nsp7-10 region.
32596311 2020. Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics?
32604797 2020. Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1.

primase complex

32535228 2020. Structural analysis of the putative SARS-CoV-2 primase complex.

nsp

32270884 2020. Role of Nonstructural Proteins in the Pathogenesis of SARS-CoV-2


32275073 2020. Response to Ribeiro da Silva et al ,"Role of Nonstructural Proteins in the Pathogenesis of SARS-CoV-2

nsp1 protein

PHA SCR nsp1

nsp2 protein

PHA SCR nsp2

nsp3 protein

PHA SCR nsp3

nsp6 protein

PHA SCR nsp6

nsp7b


32142938 2020. Nonstructural proteins NS7b and NS8 are likely to be phylogenetically associated with evolution of 2019-nCoV

nsp8


32142938 2020. Nonstructural proteins NS7b and NS8 are likely to be phylogenetically associated with evolution of 2019-nCoV

nsp9


32592996 2020. Crystal Structure of the SARS-CoV-2 Non-structural Protein 9, Nsp9.

nsp10, nsp16 methyltransferase

PHA SCR nsp10 nsp16 methyltransferase

nsp13 protein NTPase, RNA helicase

PHA SCR nsp13 helicase, nucleotidase

nsp14

PHA SCR nsp14

nsp15 endoribonuclease NendoU

PHA SCR nsp15 endoribonuclease

papain-like proteinase

PHA SCR papain-like proteinase

replication factors, nsp12, nsp8, nsp7

PHA SCR rna-dependent rna-polymerase

nucleocapsid


32363136 ä. Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites
32302675 ä. Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses
32416961 2020. Biochemical characterization of SARS-CoV-2 nucleocapsid protein

32291557 ä. SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells
32562316 2020. A proposed role for the SARS-CoV-2 nucleocapsid protein in the formation and regulation of biomolecular condensates.
32589897 2020. The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway.


vacuolar interaction

32485205 2020. The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway.


innate interference

virus secretion

envelope
32446902 2020. Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19.


receptor binding any target

32565603 2020. Update on the target structures of SARS-CoV-2: A systematic review.


32604730 2020. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
32595513 2020. New Strategy for COVID-19: An Evolutionary Role for RGD Motif in SARS-CoV-2 and Potential Inhibitors for Virus Infection.

receptor binding: trmpss2

PHA SCR spike protein TMPRSS2

receptor binding: trmpss4

PHA SCR spike protein TMPRSS4

receptor binding: grp78, g-proteins

PHA SRC spike protein Grp78

candidate receptor binding DPP4


32405622 2020. The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike.

Uptake: cathepsin L

PHA SCR spike protein Cathepsin L

endocytosis membrane fusion


32047258 ä. Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
32265513 ä. SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion
32130973 2020. A potential role for integrins in host cell entry by SARS-CoV-2
32246503 ä. SARS?COV?2 and infectivity: Possible increase in infectivity associated to integrin motif expression

32272173 2020. Coronavirus membrane fusion mechanism offers a potential target for antiviral development


32094589 ä. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

32376634 2020. Cell entry mechanisms of SARS-CoV-2


32047128 2020. Distinct Roles for Sialoside and Protein Receptors in Coronavirus Infection

32428379 2020. Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing.


32479856 2020. SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention.


3CL proteinase and main proteinase is the same

PHA SCR main protease

orf


32357959 2020. An 81 nucleotide deletion in SARS-CoV-2 ORF7a identified from sentinel surveillance in Arizona (Jan-Mar 2020)
32371472 2020. SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis
32433742 2020. Extended ORF8 Gene Region Is Valuable in the Epidemiological Investigation of SARS-similar Coronavirus.
32555321 2020. The ORF3a protein of SARS-CoV-2 induces apoptosis in cells.
32589897 2020. The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway.
32540495 2020. Molecular conservation and differential mutation on ORF3a gene in Indian SARS-CoV2 genomes.
32504060 2020. Immune evasion via SARS-CoV-2 ORF8 protein?


varia

32452762 2020. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.


32200634 ä. Protein Structure and Sequence Reanalysis of 2019-nCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1

32289821 ä. Extreme genomic CpG deficiency in SARS-CoV-2 and evasion of host antiviral defense


32123347 ä. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
C7152894 ä. A COMPREHENSIVE ANALYSIS OF GENOME COMPOSITION AND CODON USAGE PATTERNS OF EMERGING CORONAVIRUSES
32366025 2020. Codon Usage and Phenotypic Divergences of SARS-CoV-2 Genes
32291894 2020. Cytosine drives evolution of SARS-CoV-2
32159237 ä. From SARS and MERS CoVs to SARS?CoV?2: Moving toward more biased codon usage in viral structural and nonstructural genes
32387562 2020. Coding potential and sequence conservation of SARS-CoV-2 and related animal viruses
32294518 2020. A comprehensive analysis of genome composition and codon usage patterns of emerging coronaviruses

Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis